Interferon beta-1a as a Candidate for COVID-19 Treatment; An Open-Label Single-Arm Clinical Trial

Interferon beta-1a as a Candidate for COVID-19 Treatment; An Open-Label Single-Arm Clinical Trial

Introduction: Since December 2019, an outbreak of Covid-19 has imposed growing worldwide concern. Researchers around the world is working to find a treatment or a vaccine for the Covid-19 and different treatment approaches have been tested in this regard. Objective: This study was designed and cond...

Full description

Bibliographic Details
Main Authors: Pooya Payandemehr, Morteza Azhdarzadeh, Hooman Bahrami-Motlagh, Azar Hadadi, Farhad Najmeddin, Shaghayegh Shahmirzaei, Marzieh Pazoki, Mehran Sotoodehnia, Reza Rahimian
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2020-05-01
Series:Advanced Journal of Emergency Medicine
Subjects:
Antiviral Agents
Clinical Trials as Topic
COVID-19
Interferon beta-1a
Online Access:http://ajem.tums.ac.ir/index.php/ajem/article/view/454

Internet

http://ajem.tums.ac.ir/index.php/ajem/article/view/454

Similar Items